Therapeutic MicroRNA Strategies in Human Cancer
AUTOR(ES)
Li, Chunsheng
FONTE
Springer US
RESUMO
MicroRNAs (miRNAs) are ~22 nucleotide long, noncoding, endogenous RNA molecules which exert their functions by base pairing with messenger RNAs (mRNAs), thereby regulate protein-coding gene expression. In eukaryotic cells, miRNAs play important roles in regulating biological processes such as proliferation, differentiation, apoptosis, and stem cell self-renewal. The human genome may contain as many as 1,000 miRNAs, and more than 700 of them have been identified. miRNAs are predicted to target up to one third of mRNAs. Each miRNA can target hundreds of transcripts directly or indirectly, while more than one miRNA can converge on a single transcript target. Therefore, the potential regulatory circuitry afforded by miRNA is enormous. Recently, mounting evidence implicates miRNAs as a new class of modulator for human tumor initiation and progression. Therefore, it has been proposed that manipulating miRNA activity and miRNA biogenesis may be a novel avenue for developing efficient therapies against cancer.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2782079Documentos Relacionados
- MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications
- Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer
- Human MicroRNA Targets
- MicroRNA 100: a context dependent miRNA in prostate cancer
- MicroRNA in the immune system, microRNA as an immune system